Archives of Biochemistry and Biophysics

Author Index
pp. CO2-CO2(1)

Contents by Short Title
pp. i-i(1)

Table of Contents
pp. iii-iv(2)

Picture of Dr. Estabrook
pp. vi-vi(1)

Note from the Editors
pp. 1-1(1)

Pigments of rat liver microsomes
pp. 2-6(5)
Author: Klingenberg M.

Studies on pig liver microsomes I. Enzymic and pigment composition of different microsomal fractions
pp. 7-15(9)
Author: Garfinkel D.

Ronald W. Estabrook: gifted scientist with the same versatile, energetic, and colorful qualities as cytochrome P450
pp. 16-17(2)
Author: Coon M.J.

Comparison of P450s from human and fugu: 420 million years of vertebrate P450 evolution
pp. 18-24(7)
Author: Nelson D.R.

Crystal structures of cyanide complexes of P450cam and the oxygenase domain of inducible nitric oxide synthase—structural models of the short-lived oxygen complexes
pp. 25-31(7)
Authors: Fedorov R.; Ghosh D.K.; Schlichting I.

Essential requirements for substrate binding affinity and selectivity toward human CYP2 family enzymes
pp. 32-44(13)
Author: Lewis D.F.V.

Thoughts on thiolate tethering. Tribute and thanks to a teacher
pp. 45-51(7)
Author: Ullrich V.

Aromatic stacking as a determinant of the thermal stability of CYP119 from Sulfolobus solfataricus
pp. 52-58(7)
Authors: Puchkaev A.V.; Koo L.S.; Ortiz de Montellano P.R.

Cytochrome P450 oxidations in the generation of reactive electrophiles: epoxidation and related reactions
pp. 59-71(13)
Author: Peter Guengerich F.

Multiple mechanisms and multiple oxidants in P450-catalyzed hydroxylations
pp. 72-79(8)
Authors: Newcomb M.; Hollenberg P.F.; Coon M.J.

Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid
pp. 80-91(12)
Authors: Melet A.; Assrir N.; Jean P.; Pilar Lopez-Garcia M.; Marques-Soares C.; Jaouen M.; Dansette P.M.; Sari M-A.; Mansuy D.

Analysis of homotropic and heterotropic cooperativity of diazepam oxidation by CYP3A4 using site-directed mutagenesis and kinetic modeling
pp. 92-101(10)
Authors: He Y.A.; Roussel F.; Halpert J.R.

Structural alterations of the heme environment of cytochrome P450cam and the Y96F mutant as deduced by resonance Raman spectroscopy
pp. 102-112(11)
Authors: Niaura G.; Reipa V.; Mayhew M.P.; Holden M.; Vilker V.L.

Structure–function relationships of rat liver CYP3A9 to its human liver orthologs: site-directed active site mutagenesis to a progesterone dihydroxylase
pp. 113-126(14)
Authors: Xue L.; Zgoda V.G.; Arison B.; Almira Correia M.

Functional analysis of the molecular determinants of cyclooxygenase-2 acetylation by 2-acetoxyphenylhept-2-ynyl sulfide
pp. 127-133(7)
Authors: Phillip Hochgesang G.; Nemeth-Cawley J.F.; Rowlinson S.W.; Caprioli R.M.; Marnett L.J.

The enantiomer of progesterone (ent-progesterone) is a competitive inhibitor of human cytochromes P450c17 and P450c21
pp. 134-144(11)
Authors: Auchus R.J.; Sampath Kumar A.; Andrew Boswell C.; Gupta M.K.; Bruce K.; Rath N.P.; Covey D.F.

Ovine steroid 17-hydroxylase cytochrome P450: characteristics of the hydroxylase and lyase activities of the adrenal cortex enzyme
pp. 145-152(8)
Authors: Swart P.; Lombard N.; Swart A.C.; van der Merwe T.; Murry B.A.; Nicol M.; Ian Mason J.

Study of P450 function using gene knockout and transgenic mice
pp. 153-158(6)
Authors: Gonzalez F.J.; Kimura S.

Many facets of mammalian lanosterol 14-demethylase from the evolutionarily conserved cytochrome P450 family CYP51
pp. 159-171(13)
Authors: Debeljak N.; Fink M.; Rozman D.

Evaluation of thyroid hormone effects on liver P450 reductase translation
pp. 172-179(8)
Authors: Apletalina E.V.; Li H-C.; Waxman D.J.

Metabolic pathways of dioxin by CYP1A1: species difference between rat and human CYP1A subfamily in the metabolism of dioxins
pp. 180-187(8)
Authors: Shinkyo R.; Sakaki T.; Ohta M.; Inouye K.

Expression of CYP4F8 (prostaglandin H 19-hydroxylase) in human epithelia and prominent induction in epidermis of psoriatic lesions
pp. 188-196(9)
Authors: Stark K.; To¨rma¨ H.; Cristea M.; H Oliw E.

Identification of novel enzyme–prodrug combinations for use in cytochrome P450-based gene therapy for cancer
pp. 197-206(10)
Authors: Baldwin A.; Huang Z.; Jounaidi Y.; Waxman D.J.

The role of the nuclear receptor CAR as a coordinate regulator of hepatic gene expression in defense against chemical toxicity
pp. 207-211(5)
Authors: Yamamoto Y.; Kawamoto T.; Negishi M.

Differential regulation of human CYP4A genes by peroxisome proliferators and dexamethasone
pp. 212-220(9)
Authors: Savas U.; Hsu M-H.; Johnson E.F.

Characterization of the CYP4A11 gene, a second CYP4A gene in humans
pp. 221-227(7)
Authors: Bellamine A.; Wang Y.; Waterman M.R.; Gainer III J.V.; Dawson E.P.; Brown N.J.; Capdevila J.H.

Cytochrome-P450 phosphorylation as a functional switch
pp. 228-234(7)
Authors: Oesch-Bartlomowicz B.; Oesch F.

CYP79B1 from Sinapis alba converts tryptophan to indole-3-acetaldoxime
pp. 235-241(7)
Authors: Naur P.; Hansen C.H.; Bak S.; Hansen B.G.; Jensen N.B.; Nielsen H.L.; Halkier B.A.